Fuji Pharma Past Earnings Performance

Past criteria checks 4/6

Fuji Pharma has been growing earnings at an average annual rate of 8.7%, while the Pharmaceuticals industry saw earnings growing at 5.6% annually. Revenues have been growing at an average rate of 2.6% per year. Fuji Pharma's return on equity is 13.4%, and it has net margins of 13.8%.

Key information

8.7%

Earnings growth rate

15.7%

EPS growth rate

Pharmaceuticals Industry Growth3.4%
Revenue growth rate2.6%
Return on equity13.4%
Net Margin13.8%
Next Earnings Update08 Aug 2024

Recent past performance updates

Impressive Earnings May Not Tell The Whole Story For Fuji Pharma (TSE:4554)

May 21
Impressive Earnings May Not Tell The Whole Story For Fuji Pharma (TSE:4554)

Recent updates

Fuji Pharma (TSE:4554) Is Increasing Its Dividend To ¥22.50

Jul 03
Fuji Pharma (TSE:4554) Is Increasing Its Dividend To ¥22.50

Fuji Pharma (TSE:4554) Has Announced That It Will Be Increasing Its Dividend To ¥22.50

Jun 19
Fuji Pharma (TSE:4554) Has Announced That It Will Be Increasing Its Dividend To ¥22.50

Impressive Earnings May Not Tell The Whole Story For Fuji Pharma (TSE:4554)

May 21
Impressive Earnings May Not Tell The Whole Story For Fuji Pharma (TSE:4554)

Fuji Pharma (TSE:4554) Will Pay A Larger Dividend Than Last Year At ¥22.50

May 13
Fuji Pharma (TSE:4554) Will Pay A Larger Dividend Than Last Year At ¥22.50

Fuji Pharma's (TSE:4554) Dividend Will Be ¥20.00

Feb 28
Fuji Pharma's (TSE:4554) Dividend Will Be ¥20.00

Revenue & Expenses Breakdown

How Fuji Pharma makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TSE:4554 Revenue, expenses and earnings (JPY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 2443,0525,9209,3213,184
31 Dec 2341,6395,0609,1803,184
30 Sep 2340,8893,4358,3313,184
30 Jun 2338,4382,0368,9392,485
31 Mar 2336,9252,6348,1912,485
31 Dec 2235,9762,6927,7562,485
30 Sep 2235,4262,6967,3552,485
30 Jun 2234,9622,4338,3532,446
31 Mar 2234,4392,2458,3262,446
31 Dec 2134,1412,2228,4462,446
30 Sep 2133,9902,4328,3402,446
30 Jun 2134,3923,1616,8213,060
31 Mar 2134,1653,7967,1113,060
31 Dec 2034,1202,6687,3713,060
30 Sep 2033,7932,0858,0483,060
30 Jun 2033,8542,0069,5002,052
31 Mar 2034,7011,5779,4172,052
31 Dec 1934,9682,6119,0762,052
30 Sep 1936,2792,9628,9572,052
30 Jun 1937,3613,2878,9221,760
31 Mar 1938,4313,3248,8641,760
31 Dec 1838,2313,1679,0931,760
30 Sep 1837,9093,3729,0541,760
30 Jun 1837,2433,2198,9351,825
31 Mar 1836,0243,2558,6441,825
31 Dec 1736,4123,5258,2971,825
30 Sep 1735,3873,3017,8591,825
30 Jun 1735,2173,1417,5671,840
31 Mar 1734,7172,8357,3441,840
31 Dec 1634,2342,6507,1721,840
30 Sep 1634,2292,1187,4161,840
30 Jun 1633,7082,3547,0411,729
31 Mar 1633,0562,2937,1771,729
31 Dec 1532,5402,1217,4731,729
30 Sep 1531,6802,0927,2271,729
30 Jun 1531,2542,0307,4581,769
31 Mar 1530,4971,9477,2651,769
31 Dec 1430,3782,0517,0301,769
30 Sep 1429,2152,0786,7741,769
30 Jun 1428,1092,0946,9771,280
31 Mar 1427,3561,9826,7931,280
31 Dec 1326,1001,9996,2551,280
30 Sep 1325,1742,0685,9371,280

Quality Earnings: 4554 has a large one-off gain of ¥4.4B impacting its last 12 months of financial results to 31st March, 2024.

Growing Profit Margin: 4554's current net profit margins (13.8%) are higher than last year (7.1%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 4554's earnings have grown by 8.7% per year over the past 5 years.

Accelerating Growth: 4554's earnings growth over the past year (124.8%) exceeds its 5-year average (8.7% per year).

Earnings vs Industry: 4554 earnings growth over the past year (124.8%) exceeded the Pharmaceuticals industry 12.7%.


Return on Equity

High ROE: 4554's Return on Equity (13.4%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.